Printer Friendly

Antidepressants may raise cataract risk.

Washington, June 2 (ANI): Older adults who take SSRI antidepressants may be more likely to develop cataracts, says a study.

The study has been published in Ophthalmology, the journal of the American Academy of Ophthalmology.

The study, led by Mahyar Etminan, PharmD, of Vancouver Coastal Health Research Institute, Canada, assessed data for nearly 19,000 people age 65 or older, all of whom also had cardiovascular disease. Their records were compared to about 190,000 controls.

The effect was strongest for three SSRIs: Luvox (fluvoxamine) increased risk by 39 percent, Effexor (venlafaxine) by 33 percent and Paxil (paroxetine) by 23 percent.

The apparent increased risk was associated only with current, not past, drug use. Some antidepressants did not appear to be associated with cataract risk, but this could have been because the numbers of study participants using these drug types were too small to show effects, or because only specific agents in certain medications are related to cataract formation.

"The eye's lens has serotonin receptors, and animal studies have shown that excess serotonin can make the lens opaque and lead to cataract formation," Dr. Etminan said. "If our findings are confirmed in future studies, doctors and patients should consider cataract risk when prescribing some SSRIs for seniors," he added. (ANI)

Copyright 2009 Asian News International (ANI) - All Rights Reserved.

Provided by Syndigate.info an Albawaba.com company
COPYRIGHT 2010 Al Bawaba (Middle East) Ltd.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2010 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:Asian News International
Date:Jun 2, 2010
Words:227
Previous Article:Romantic relationships can lower substance use in youngsters.
Next Article:Calcium consumption may up prostate cancer risk in Chinese.
Topics:

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters